Published in Virology on December 01, 1983
Detection of a fourth orbivirus non-structural protein. PLoS One (2011) 2.11
Bioinformatic analysis suggests that the Orbivirus VP6 cistron encodes an overlapping gene. Virol J (2008) 1.54
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol (2001) 1.19
Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment. J Virol (2012) 1.02
Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin. J Virol (1987) 1.01
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (1981) 5.66
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61
Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase. Virology (1983) 1.51
Biochemical map of polypeptides specified by foot-and-mouth disease virus. J Virol (1984) 1.46
Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology (1982) 1.44
Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol (1999) 1.43
Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol (1995) 1.42
Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods. J Virol (1986) 1.41
In vitro protein-synthesizing activity of vesicular stomatitis virus-infected cell extracts. J Virol (1973) 1.37
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol (1996) 1.35
Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein. J Virol (1998) 1.30
Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus. J Virol (1992) 1.29
Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol (2001) 1.28
Foot-and-mouth disease virion RNA: studies on the relation between the length of its 3'-poly(A) segment and infectivity. Virology (1979) 1.25
Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology (1997) 1.24
Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23
Glycans as targets for monoclonal antibodies that protect rats against Trichinella spiralis. Glycobiology (1994) 1.23
Novel tyvelose-containing tri- and tetra-antennary N-glycans in the immunodominant antigens of the intracellular parasite Trichinella spiralis. Glycobiology (1994) 1.21
The structural polypeptides of aphthovirus are phosphoproteins. Proc Natl Acad Sci U S A (1980) 1.20
Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci U S A (1985) 1.19
Isolation of foot-and-mouth disease virus messenger RNA from membrane-bound polyribosomes and characterization of its 5' and 3' termini. Virology (1979) 1.16
Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine (1998) 1.16
The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis (2011) 1.15
Midgut and salivary gland transcriptomes of the arbovirus vector Culicoides sonorensis (Diptera: Ceratopogonidae). Insect Mol Biol (2005) 1.14
Bovine cells expressing bovine herpesvirus 1 (BHV-1) glycoprotein IV resist infection by BHV-1, herpes simplex virus, and pseudorabies virus. J Virol (1990) 1.14
Inhibition of growth of zoopathogenic fungi by garlic extract. Mycologia (1976) 1.13
Molting, ecdysis, and reproduction of Trichinella spiralis are supported in vitro by intestinal epithelial cells. Infect Immun (2002) 1.11
Inhibition of fungal growth by garlic extract. Mycologia (1975) 1.10
Identification and characterization of messenger ribonucleoprotein complexes from vesicular stomatitis virus-infected HeLa cells. Virology (1977) 1.08
Life-phase specific induction and expression of rapid expulsion in rats suckling Trichinella spiralis-infected dams. Immunology (1985) 1.08
Resistance and susceptibility of bovine cells expressing herpesviral glycoprotein D homologs to herpesviral infections. Virology (1993) 1.07
Monoclonal antibody-defined human lung cell surface protein antigens. Cancer Res (1982) 1.06
Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus. Virology (1995) 1.04
Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J Virol (1991) 1.04
The role of mucus in antibody-mediated rapid expulsion of Trichinella spiralis in suckling rats. Immunology (1990) 1.03
Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus. J Gen Virol (2007) 1.02
Phosphorylcholine-containing N-glycans of Trichinella spiralis: identification of multiantennary lacdiNAc structures. Glycobiology (2000) 1.01
Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids. Clin Diagn Lab Immunol (2005) 1.00
Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res (1998) 0.99
Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine (2001) 0.99
Rapid expulsion of Trichinella spiralis in suckling rats. Science (1984) 0.99
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology (1999) 0.99
Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus. J Virol (1983) 0.99
Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses. Virology (1987) 0.97
Rapid expulsion of Trichinella spiralis in adult rats mediated by monoclonal antibodies of distinct IgG isotypes. Immunology (1992) 0.96
Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. J Virol (1985) 0.96
The role of the antibody Fc region in rapid expulsion of Trichinella spiralis in suckling rats. Immunology (1991) 0.95
Characterization of a nonstructural phosphoprotein of two orbiviruses. Virus Res (1988) 0.95
Quantifying viral propagation in vitro: toward a method for characterization of complex phenotypes. Biotechnol Prog (2001) 0.93
Current knowledge on the biochemistry and immunology of bluetongue. Prog Vet Microbiol Immunol (1985) 0.93
Monoclonal antibody analysis of bovine herpesvirus-1 glycoprotein antigenic areas relevant to natural infection. Virology (1988) 0.92
Expression in Escherichia coli and purification of biologically active L proteinase of foot-and-mouth disease virus. Virus Res (1995) 0.91
pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs. Biotechniques (2001) 0.91
Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody. Infect Immun (1983) 0.91
Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. Virology (1992) 0.91
Intestinal mucus entrapment of Trichinella spiralis larvae induced by specific antibodies. Immunology (1991) 0.91
Workshop on a detailed characterization of Trichinella spiralis antigens: a platform for future studies on antigens and antibodies to this parasite. Parasite Immunol (1996) 0.91
Vesicular stomatitis New Jersey virus glycoprotein gene sequence and neutralizing epitope stability in an enzootic focus. Virology (1990) 0.90
The effect of bovine herpesvirus type 1 glycoproteins gI and gIII on herpesvirus infections. J Gen Virol (1989) 0.90
Terminal beta-linked tyvelose creates unique epitopes in Trichinella spiralis glycan antigens. Glycobiology (1997) 0.90
Serological monitoring of vesicular stomatitis New Jersey virus in enzootic regions of Costa Rica. Am J Trop Med Hyg (1990) 0.90
Studies on the mechanism for entry of vesicular stomatitis virus glycoprotein G mRNA into membrane-bound polyribosome complexes. J Cell Biol (1977) 0.89
Persistence of vesicular stomatitis virus New Jersey RNA in convalescent hamsters. Virology (1996) 0.89
Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies. Virus Res (1986) 0.89
Rapid detection of vesicular stomatitis virus New Jersey serotype in clinical samples by using polymerase chain reaction. J Clin Microbiol (1993) 0.89
Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli. Virology (1993) 0.88
The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. Vet Microbiol (1995) 0.88
Ovine herpesvirus-2 glycoprotein B sequences from tissues of ruminant malignant catarrhal fever cases and healthy sheep are highly conserved. J Gen Virol (2001) 0.88
Bovine herpesvirus 1 U(L)3.5 interacts with bovine herpesvirus 1 alpha-transinducing factor. J Virol (2000) 0.88
Bovine herpes mammillitis in two New York dairy herds. J Am Vet Med Assoc (1982) 0.88
Immunity to Trichinella spiralis muscle infection. Vet Parasitol (2008) 0.87
The 5' end of foot-and-mouth disease virion RNA contains a protein covalently linked to the nucleotide pUp. Arch Virol (1980) 0.87
Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits. Vaccine (1989) 0.87
In vitro morphogenesis of foot-and-mouth disease virus. J Virol (1984) 0.87
Larvae-induced plasma membrane wounds and glycoprotein deposition are insufficient for Trichinella spiralis invasion of epithelial cells. Mol Biochem Parasitol (2000) 0.87
Molecular analysis of antigens targeted by protective antibodies in rapid expulsion of Trichinella spiralis. Mol Biochem Parasitol (1994) 0.86
Mechanisms of bovine herpesvirus type 1 neutralization by monoclonal antibodies to glycoproteins gI, gIII and gIV. J Gen Virol (1992) 0.86
Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines. Vaccine (1988) 0.86
Trichinella spiralis: the effect of specific antibody on muscle larvae in the small intestines of weaned rats. Exp Parasitol (1993) 0.86
Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and immunogenicity. Vaccine (1997) 0.85
Heterogeneity of neutralization-related epitopes within a bluetongue virus serotype. Virology (1983) 0.85
Engineering better vaccines for foot-and-mouth disease. Dev Biol (Basel) (2003) 0.85
The bovine herpesvirus type 1 UL3.5 open reading frame encodes a virion structural protein. Virology (1998) 0.84
Presence of African horse sickness virus in equine tissues, as determined by in situ hybridization. Vet Pathol (1994) 0.84
Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants. Virology (1983) 0.84
Identification of a protein kinase activity in purified foot- and-mouth disease virus. J Virol (1981) 0.83
Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus. Viral Immunol (2009) 0.83
Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol (1998) 0.83
Characterization of African swine fever virus antigenic proteins by immunoprecipitation. Arch Virol (1984) 0.83
Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J Biotechnol (1999) 0.83